Aristogene Biosciences Pvt. Ltd.
Driven by a team of Women technocrats with a cumulative experience of over 100 years in the fields of life sciences, Aristogene is amongst the first companies in the world to develop and commercialise bacteriophage products for treatment of infections in poultry and aquaculture. Aristogene has filed three patents for the products in aquaculture. We are a biotech company based in Bangalore driven …
Profile
- Industry
- Biorefining, Diagnostics, Fishery & aquaculture, Industrial chemistry, Post-harvest & processing, Seeds & genetics, Veterinary
- Topics
- Livestock & poultry production/genetics, Shrimp/fish genetics & aquaculture tech, Enzymes & biocatalysis, Organic acids & bio-based chemicals
- Role
- Producer — “…ombines scientific R&D with manufacturing capabilities to supply veterinary and agricultural sectors globally,…”
- Why it is bioeconomy
- Aristogene Biosciences is a biotechnology company that develops and commercializes bacteriophage-based products for the treatment of infections in poultry, aquaculture, and livestock.
- Found via
- Fermbox Bio; [Rubric] Hong Kong · phages; [Rubric] India · animal-vaccines; [Rubric] India · phages
Bio-solutions it supplies 1
What they offer
Products: Bacteriophage Product for Aeromonas; Bacteriophage Products for Livestock; Bacteriophage products; Vibrioshield; Elixir; Colishield; Salshield; VibZet; EShield
Certifications: BIRAC INNOVATOR AWARD; DSIR recognized R & D Centre
- Applications
- Livestock · Poultry · Aquaculture · Agriculture
- Certifications (website)
- BIRAC INNOVATOR AWARD · DSIR recognized R & D Centre
- Production sites
- Bangalore — Enzymes, biochemicals, reagents, bacteriophage products · Bangalore — Bacteriophage products
- Products (website)
- Bacteriophage Product for Aeromonas — Currently underway for Containing Aeromonas affecting Fisheries. · Bacteriophage Products for Livestock — Products for treatment of infections in Livestock. · Bacteriophage products — Developing Bacteriophage products for treatment of infections in Livestock, Poultry, Aquaculture and Agriculture · Vibrioshield — Bacteriophage product for treatment of infections in poultry and aquaculture. · Elixir — Bacteriophage product for treatment of infections in poultry and aquaculture. · Colishield — Bacteriophage product for treatment of infections in poultry and aquaculture. · Salshield — Bacteriophage product for treatment of infections in poultry and aquaculture. · VibZet — Bacteriophage product for treatment of infections in poultry and aquaculture. · VibZet™ — An all-natural, non-chemical antimicrobial phage-biotic specifically designed to guard against vibrio infection in shrimp nurseries. · Vibrioshield — VIBRIOSHIELD is an all-natural, non-chemical antimicrobial preparation for controlling the Vibriosis. · Elixir — The active ingredients of ELIXIR are naturally occurring bacteriophages that selectively and specifically kill vibrios. · VibZet — TM VibZetTM by ARISTOGENE, an all-natural, non-chemical antimicrobial phage-biotic, is the best option for guarding against vibrio infection in shrimp nurseries.
- R&D facilities
- Thrust on Continuous research in development of newer bacteriophage products · Custom Services in the domain of genomics and proteomics
Read from the company's own website: about · products · production · rnd · leadership · contact · sustainability · topic
News & status 6
- 2026-03-27 Aristo Bio-Tech and Lifescience Limited Empaneled as Supplier by National Fertilizers LimitedThe article is about Aristo Bio-Tech and Lifescience Limited (not Aristogene Biosciences Pvt. Ltd.) being empanelled as an approved supplier by National Fertilizers Limited for technical grade molecules, effective March 17, 2026 to March 16, 2029, enabling …
- 2026-05-29 Aristo Bio-Tech files SDD compliance certificate for FY26The item is about Aristo Bio-Tech and Lifescience Limited (not Aristogene Biosciences Pvt. Ltd.), reporting that its Structured Digital Database (SDD) for FY26 meets SEBI PIT/SDD requirements, with all 4 UPSI events captured, 8-year record retention, and a …
- 2026-04-02 Aristo Bio-Tech Secures ₹20.3 Million in New Orders, Boosting Growth Prospects | Wow NewsAristo Bio-Tech and Lifescience Limited (Aristogene Biosciences Pvt. Ltd.) announced new purchase orders totaling ₹20.3 million, including a ₹17.03 million order from National Pesticides & Chemicals, signaling growth and a stronger order book in the …
- 2025-07-24 ORF Biologics, Inc. and Vipragen Biosciences Pvt. Ltd. Forge Strategic Alliance to Advance Biologics Research and Assay Development - ORF BiologicsThe page reports a strategic alliance between ORF Biologics, Inc. and Vipragen Biosciences Pvt. Ltd. (not Aristogene Biosciences Pvt. Ltd.), focusing on recombinant protein expression and assay development for biologics. It does not mention Aristogene …
- 2025-09-22 Life saving drug Hetero Healthcare Limited launches Perzea – India’s most affordable in collaboration with Enzene Biosciences, expanding access to breast cancer therapy. | GOVINDA REDDY KThe provided content does not mention Aristogene Biosciences Pvt. Ltd.; it focuses on Hetero Healthcare’s Perzea (a Pertuzumab biosimilar) launched in collaboration with Enzene Biosciences and Enzene’s biologics manufacturing capabilities. Therefore, there is …
- 2026-08-03 Goldman Sachs-backed Aragen Life Sciences eyes up to Rs 3,500-crore IPO; to file DRHP soonThe article is about Aragen Life Sciences (not Aristogene Biosciences Pvt. Ltd.) planning an IPO to raise up to ₹3,500 crore, with funds to repay debt and fund growth projects as it expands its R&D and manufacturing capabilities.
Network: owners, partners, peers
Similar companies
SALEM MICROBES PRIVATE LIMITED · ctcbio Inc. · Hester Biosciences Limited · Choong Ang Vaccine Laboratories Co., Ltd. · Ringpu Biology · Proteon Pharmaceuticals India · Malaysian Vaccine and Pharmaceuticals · VH GROUP
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member